Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Bernhard Hemmer, Emmanuelle Waubant et al.|The Lancet Neurology|2021Cited by 518
<scp>IL</scp>‐33 attenuates EAE by suppressing <scp>IL</scp>‐17 and <scp>IFN</scp>‐γ production and inducing alternatively activated macrophagesHui‐Rong Jiang, Foo Y. Liew, José C. Alves‐Filho et al.|European Journal of Immunology|2012Cited by 304
Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potentialKatja Thümmler, Christopher Linington, Eran Rom et al.|Acta Neuropathologica Communications|2019Cited by 23
Fibroblast growth factor 9 (FGF9)‐mediated neurodegeneration: Implications for progressive multiple sclerosis?Katja Thümmler, Christopher Linington, Claudia Wrzos et al.|Neuropathology and Applied Neurobiology|2023Cited by 7
Selective Toxicity of BIP Inducer X Towards Microglia and Oligodendrocytes In&nbsp; <i>In&nbsp;Vitro</i> and <i>Ex Vivo</i>&nbsp;Models of MyelinationUna FitzGerald, Heinz‐Peter Nasheuer, Enrico Bagnoli et al.|SSRN Electronic Journal|2022Cited by 0